Endotoxin-induced cross-tolerance to Gram-positive sepsis

Journal of Endotoxin Research

Volumn 5, Issue 3, 1999, Pages 119-126

  Guyton, Kelly ^a   Bond, Robert ^c   Romeo, Cristina ^d   Southern, Rodney ^b   Cochran, Joel ^a   Teti, Giuseppe ^d   Cook, James A ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ENDOTOXIN; GALACTOSAMINE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; THROMBOXANE B2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CROSS TOLERANCE; ENZYME ACTIVATION; GRAM POSITIVE BACTERIUM; MACROPHAGE ACTIVATION; MALE; NONHUMAN; PERITONEUM MACROPHAGE; RAT; SALMONELLA ENTERITIDIS; SEPSIS; STREPTOCOCCUS AGALACTIAE;

ANIMALIA; BACTERIA (MICROORGANISMS); ENTERITIDIS; NEGIBACTERIA; POSIBACTERIA; SALMONELLA ENTERITIDIS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS SP. 'GROUP B';

EID: 0032844496     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1179/096805199101531624     Document Type: Article

References (48)

1. Bone RC. The pathogenesis of sepsis. Ann Intern Med 1991; 115: 457-469.
2. Sweet MJ, Hume DA. Endotoxin signal transduction in macrophages. J Leukoc Biol 1996; 60: 8-26.
3. Fenton MJ, Golenbock DT. LPS-binding proteins and receptors. J Leukoc Biol 1998; 64: 25-32.
4. Geppert TD, Whitehurst CE, Thompson P, Beutler B. Lipopolysaccharide signals activation of tumor necrosis factor biosynthesis through the ras/raf-1/MEK/MAPK pathway. Mol Med 1994; 1: 93-103.
5. Weinstein SL, June CH, DeFranco AL. Lipopolysaccharide-induced protein tyrosine phosphorylation in human macrophages is mediated by CD14. J Immunol 1993; 151: 3829-3838.
6. Geng Y, Zhang B, Lotz M. Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes. J Immunol 1993; 151: 6692-6700.
7. Weinstein SL, Sanghera JS, Lemke K, DeFranco AL, Pelech SL. Bacterial lipopolysaccharide induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in macrophages. J Biol Chem 1992; 267: 14955-14962.
8. Matsuda S, Gotoh, Y, Nishida E. Signaling pathways mediated by the mitogen-activatcd protein (MAP) kinase kinase/MAP kinase cascade. J Leukoc Biol 1994; 56: 548-553.
9. Heumann D, Barras C, Severin A, Glauser MP, Tomasz A. Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect Immun 1994; 62: 2715-2721.
10. Timmerman CP, Mattsson E, Martinez-Martinez L et al. Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans. Infect Immun 1993; 61: 4167-4172.
11. Kusunoki T, Hailman E, Juan TS, Lichcnstein HS, Wright SD. Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune response. J Exp Med 1995; 182: 1673-1682.
12. Weidemann B, Brade H, Rietschel ET et al. Soluble peptidoglycan-induced monokine production can be blocked by anti-CD 14 monoclonal antibodies and by lipid A partial structures. Infect Immun 1994; 62: 4709-4715.
13. Greisman SE, Woodward WE. Mechanisms of endotoxin tolerance. III. The refractory state during continuous intravenous infusions of endotoxin. J Exp Med 1965; 121: 911-933.
14. Mengozzi M, Fantuzzi C, Sironi M et al. Early down-regulation of TNF production by LPS tolerance in human monocytes: comparison with IL-1 beta, IL-6, and IL-8. Lymphokine Cytokine Res 1993; 12: 231-236.
15. Takasuka N, Tokunaga T, Akagawa KS. Pre-exposure of macrophages to low doses of lipopolysaccharide inhibits the expression of tumor necrosis factor-alpha mRNA but not of IL-1 beta mRNA. J Immunol 1991; 146: 3824-3830.
16. Ziegler-Heitbrock HW, Wedel A, Schraut W et al. Tolerance to lipopolysaccharide involves mobilization of nuclear factor kappa B with predominance of p50 homodimers. J Biol Chem 1994; 269: 17001-17004.
17. Marchant A, Gueydan C, Houzet L et al. Defective translation of tumor necrosis factor mRNA in lipopolysaccharide-tolerant macrophages. J Inflamm 1996; 46: 114-123.
18. Durando MM, Meier KE, Cook JA. Endotoxin activation of mitogen-activated protein kinase in THP-1 cells; diminished activation following endotoxin desensitization. J Leukoc Biol 1998; 64: 259-264.
19. Shnyra A, Brewington R, Alipio A, Amura C, Morrison DC. Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12. J Immunol 1998; 160: 3729-3736.
20. Takasuka N, Matsuura K, Yamamoto S, Akagawa KS. Suppression of TNFalpha mRNA expression in LPS-primed macrophages occurs at the level of nuclear factor-kappa B activation, but not at the level of protein kinase C or CD14 expression. J Immunol 1995; 154: 4803-4812.
21. 2 mimetic and phenylephrine. J Cardiovasc Pharmacol 1991; 17: 20-26.
22. Zingarelli B, Halushka PV, Caputi AP, Cook JA. Increased nitric oxide synthesis during the development of endotoxin tolerance. Shock 1995; 3: 102-108.
23. Frankenberger M, Pechumer H, Ziegler-Heilbrock HW. Interleukin-10 is unregulated in LPS tolerance. J Inflamm 1995; 45: 56-63.
24. Fahmi H, Chaby R. Desensitization of macrophages to endotoxin effects is not correlated with a down-regulation of lipopolysaccharide-binding sites. Cell Immunol 1993; 150: 219-229.
25. Granowitz EV, Porat R, Mier JW et al. Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans. J Immunol 1993; 151: 1637-1645.
26. Cavaillon JM, Pitton C, Fitting C. Endotoxin tolerance is not a LPS specific phenomenon: partial mimicry with IL-1, IL-10 and TGFP. J Endotoxin Res 1994; 1: 21-29.
27. Mathison JC, Virca GD, Wolfson E, Tobias PS, Claser R, Ulevitch RJ. Adaption to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages. J Clin Invest 1990; 85: 1108-1118.
28. Kreutz M, Ackermann U, Hauschildt S et al. A comparative analysis of cytokine production and tolerance induction by bacterial lipopeptides, lipopolysaccharides and Staphylococcus aureus in human monocytes. Immunology 1997; 92: 396-401.
29. Mengozzi M, Ghezzi P. Cytokine down-regulation in endotoxin tolerance. Eur Cytokine Netw 1993; 4: 89-98.
30. Roth J, Asian T, Storr B, Zeisberger E. Lack of cross tolerance between LPS and muramyl dipeptide in induction of circulating TNF-α and IL-6 in guinea pigs. Am J Physiol 1997; 273: R1529-R1533.
31. Barker CJ, Edwards MS. Group B streptococcal infections. In: Remington JS, Klein JO, eds. Infectious Diseases of the Fetus and Newborn Infant, 3rd edn. Philadelphia, PA: Saunders, 1990: 742-911.
32. Freudenberg MA, Galanos C. Tumor necrosis factor alpha mediates lethal activity of killed Gram-negative and Gram-positive bacteria in D-galactosamine-treated mice. Infect Immun 1991; 59: 2110-2115.
33. Rogers TS, Halushka PV, Wise WC, Cook JA. Differential alteration of lipoxygenase and cyclooxygenase metabolism by rat peritoneal macrophages induced by endotoxin tolerance. Prostaglandins 1986; 31: 639-650.
34. Ruff MR, Gifford CE. Rabbit tumor necrosis factor: mechanism of action. Infect Immun 1981; 31: 380-385.
35. Durando M, Ashton SH, Makhlouf MA et al. Endotoxin-induced desensitization of THP-1 cells is not associated with altered G protein binding or content. J Endotoxin Res 1997; 4: 97-103.
36. 15N]-nitrate in biological fluids. Anal Biochem 1982; 126: 131-138.
37. Laemmli UK. Cleavage of structural proteins during the assembly of bacteriophage T4. Nature 1970; 227: 680-685.
38. Mancuso G, Blandino G, Cusumano V et al. Cross-tolerance between bacterial endotoxin and group B Streptococcus in neonatal rats. J Endotoxin Res 1994; 1: 114-119.
39. Goodrum, KJ, McCormick LL, Schneider B. Group B streptococcus-induced nitric oxide production in murine macrophages is CR3(CD11b/CD18) dependent. Infect Immun 1994; 62: 3102-3107.
40. Williams PA, Bohnsack JF, Augustine NH, Drummond WK, Rubens CE, Hill HR. Production of tumor necrosis factor by human cells in vitro and in vivo, induced by group B streptococci. J Pediatr 1993; 123: 292-300.
41. Barefield ES, Hicks TP, Philips JB 3rd. Thromboxane and pulmonary morphometry in the development of the pulmonary hypertensive response to group B streptococcus. Crit Care Med 1994; 22: 506-514.
42. Cusumano V, Mancuso G, Cenovese F et al. Neonatal hypersusceptibility to endotoxin correlates with increased tumor necrosis factor production in mice. J Infect Dis 1997; 176: 168-176.
43. Kilbourn RG, Szabo C, Traber DL. Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: lessons learned from experimental and clinical studies. Shock 1997; 7: 235-246.
44. Makhlouf M, Ashton SH, Hildebrandt L et al. Alterations in macrophage C proteins are associated with endotoxin tolerance. Biochim Biophys Acta 1996; 1312: 163-168.
45. Coffee KA, Halushka PV, Wise WC, Cook JA. Altered responses to modulators of guanine nucleotide binding protein activity in endotoxin tolerance. Biochim Biophys Acta 1990; 1035: 201-205.
46. i2 in the promonocytic cell line U937. J Biol Chem 1989; 264: 20240-20247.
47. i2-mediated activation of the MAP kinase cascade. Mol Biol Cell 1995; 6: 1685-1695.
48. Wan Y, Kurosaki T, Huang XY. Tyrosine kinases in activation of the MAP kinase cascade by G-protein coupled receptors. Nature 1996; 380: 541-544.